Novel biomarkers in plasma cell disorders

The University of Sussex (2011) Novel biomarkers in plasma cell disorders. WO/2012/080721 A2.

[img]
Preview
PDF
Download (1MB) | Preview

Abstract

The invention relates to novel biomarkers for plasma cell disorders, such as multiple myeloma,and in particular the use of microRNAs as diagnostic and prognostic markers in assyas for detecting such disorders. The invention also relates to methods of determining the efficacy of treating such a plasma cell disorder with a therapeutic agent and kits for carrying out the assays and methods. The assays are qualitative and/or quantitative and are adaptable to large-scale screening and clinical trials.

Item Type: Patent
Schools and Departments: Brighton and Sussex Medical School > Clinical and Experimental Medicine
Brighton and Sussex Medical School > Primary Care and Public Health
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology Including cancer and carcinogens
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology Including cancer and carcinogens > RC0270.8 Therapeutics
Depositing User: Sarah Newbury
Date Deposited: 09 Nov 2012 14:43
Last Modified: 18 Feb 2022 16:33
URI: http://sro.sussex.ac.uk/id/eprint/42254

View download statistics for this item

📧 Request an update
Project NameSussex Project NumberFunderFunder Ref
Drug-induced selective lethality in populations of DNMT3A knockdown cellsG2782WELLCOME TRUST218435/Z/19/Z
How does SARS CoV-2 infect blood vessels?G3146UK RESEARCH AND INNOVATIONMR/V036750/1
In vitro modelling and therapeutic targeting of tumour cell migration in chronic lymphocytic leukaemia.G2544BLOODWISE18005
Mining the Wnt signalling-responsive surfaceome for drug targets in acute myeloid leukaemiaG3090WELLCOME TRUSTUnset
Modelling and targeting Acute Myeloid Leukaemia cells in the Bone Marrow protective nicheG3106SUSSEX CANCER FUND FOR TREATMENT AND RESEARCHUnset